NLM Digital Collections

Search

Start Over Publication Year 2017 ✖Remove constraint Publication Year: 2017

431. Climate change: information on potential economic effects could help guide federal efforts to reduce fiscal exposure : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, September 2017
Subject(s):
Climate Change -- economics
Global Warming -- economics
Models, Economic
Agriculture
Crime
Electric Power Supplies
Environment
Greenhouse Effect
Greenhouse Gases -- adverse effects
Health
Natural Resources
Risk Assessment
Humans
United States

432. Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Health Services Accessibility
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Outcome Assessment (Health Care)
Community-Institutional Relations
Buprenorphine -- therapeutic use
Inservice Training
Insurance Coverage
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Prescription Drug Diversion -- prevention & control
Humans
United States
United States. Department of Health and Human Services.

433. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Analgesics, Opioid -- therapeutic use
Drug Utilization Review
Government Regulation
Inappropriate Prescribing
Medicare Part D
Prescription Drug Misuse
Fraud -- prevention & control
Opioid-Related Disorders
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

434. Federal employees health benefits program: enrollment remains concentrated despite more plan offerings, and effects of adding plan types are uncertain : report to the ranking member, Committee on Oversight and Government Reform, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Federal Government
Health Benefit Plans, Employee -- statistics & numerical data
Insurance Carriers
Forecasting
Government Employees
Health Benefit Plans, Employee -- trends
Medicare
Humans
United States

435. Counternarcotics: overview of U.S. efforts in the Western Hemisphere : report to the ranking member, Committee on Foreign Affairs, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Drug and Narcotic Control -- organization & administration
Drug Trafficking -- prevention & control
Government Agencies
Street Drugs
Drug and Narcotic Control -- economics
Drug and Narcotic Control -- trends
Forecasting
Information Dissemination
Interinstitutional Relations
Humans
North America
South America
United States

436. Preventing drug abuse: low participation by pharmacies and other entities as voluntary collectors of unused prescription drugs : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Drug and Narcotic Control
Prescription Drug Diversion -- prevention & control
Prescription Drug Misuse -- prevention & control
Voluntary Programs
Government Programs
Pharmacies
Prescription Drugs
State Government
Humans
United States
United States. Drug Enforcement Administration.

437. Low-dose radiation: interagency collaboration on planning research could improve information on health effects : testimony before the Subcommittee on Energy, Committee on Science, Space, and Technology, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, November 1, 2017
Subject(s):
Government Agencies
Interinstitutional Relations
Radiation Effects
Radiation, Ionizing
Research
Radiation Dosage
Humans
United States
United States. Department of Energy.
United States. Environmental Protection Agency.
United States. Food and Drug Administration.
U.S. Nuclear Regulatory Commission.

438. High-containment laboratories: coordinated efforts needed to further strengthen oversight of select agents : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, November 2, 2017
Subject(s):
Biological Warfare Agents
Chemical Warfare Agents
Government Regulation
Laboratories
Bacterial Toxins
Interinstitutional Relations
Humans
Canada
United Kingdom
United States
Centers for Disease Control and Prevention (U.S.)
United States. Animal and Plant Health Inspection Service.

439. Child well-being: key considerations for policymakers including the need for a federal cross-agency priority goal : a report to Congress

Publication:
Washington, DC : United States Government Accountability Office, November 2017
Subject(s):
Child Welfare -- statistics & numerical data
Child Welfare -- trends
Health Policy
Interinstitutional Relations
Policy Making
Social Determinants of Health
Accidents -- mortality
Adolescent
African Americans
Asthma
Child
Child Abuse
Child, Preschool
Depression
Early Intervention (Education)
European Continental Ancestry Group
Educational Status
Federal Government
Food Supply
Forecasting
Goals
Health Services Accessibility
Health Status
Hispanic Americans
Homeless Persons
Housing
Infant
Insurance Coverage
Local Government
Poverty
Pregnancy Outcome
Smoking
State Government
Substance-Related Disorders
Suicide
Humans
United States